TORONTO, May 3, 2019 /CNW/ - 48North Cannabis Corp.
("48North" or the "Company") (TSXV:NRTH), a vertically integrated
cannabis producer focused on the development of next-generation
cannabis products, previously announced that it had accelerated the
expiry of certain common share purchase warrants ("Warrants"),
bearing an expiration date of December 2,
2020. As a result, gross proceeds to the company total
$13,568,570. Of the remaining
outstanding 18,227,184 Warrants, 18,091,427 Warrants, representing
99.3% of the warrants available for exercise were exercised.
The Company intends to use the gross proceeds to fund inventory
and for working capital and general corporate purposes; including
operational expenses related to the execution of its proposed
100-acre outdoor cannabis facility and the development of
next-generation cannabis products expected to be available for
retail sale in Fall 2019.
About 48North
48North Cannabis Corp. (TSXV: NRTH) is a vertically
integrated cannabis company focused on the health and wellness
market through cultivation and extraction, as well as the creation
of innovative, authentic brands for next-generation cannabis
products. 48North is developing formulations and manufacturing
capabilities for its own proprietary products, as well as
positioning itself to contract manufacture similar products for
third parties. 48North operates two indoor-licensed cannabis
production sites in Ontario with more than 86,000
square feet of production capacity. 48North cultivates unique
genetics at its wholly owned subsidiaries, DelShen Therapeutics
Corp. ("DelShen") and 2599760 Ontario Corp. dba Good & Green
("Good & Green"), both Licensed Producers under the Cannabis
Act. In addition, subject to Health Canada approval, 48North
expects to operate a 100-acre organic farm providing 48North with
organic, sun-grown cannabis securing a significant first-mover
advantage in the production of low-cost, next-generation,
extract-based cannabis products. 48North has a growing portfolio of
brands that include Latitude, a women's cannabis platform
(explorelatitude.com), Mother & Clone, a rapid-acting
sublingual cannabis nanospray (momandclone.com) and Avitas, a
single strain vaporizer cartridge (avitasgrown.com).
DISCLAIMER & READER ADVISORY
Neither TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accept responsibility for the adequacy or
accuracy of this release. Certain statements contained in this
press release constitute forward-looking information. These
statements relate to future events or future performance. The use
of any of the words "could," "intend," "expect,"
"believe," "will," "projected," "estimated" and similar expressions
and statements relating to matters that are not historical facts
are intended to identify forward-looking information and are based
on the parties' current belief or assumptions as to the outcome and
timing of such future events. Actual future results may differ
materially. Forward-looking statements in this news release include
statements relating to the business plan and future operations of
the Company, including its application with Health Canada for a
cultivation licence for its 100-acre outdoor grow property. Such
statements are subject to risks and uncertainties that may cause
actual results, performance or developments to differ materially
from those contained in the forward-looking statements, including
the possibility that the business plan described herein will not be
completed, that 48North may not derive the expected benefits from
such business plans, or that applicable regulatory approvals will
be obtained to carry out the activities contemplated herein. The
business of the Company is subject to a number of material risks
and uncertainties. Please refer to the Company's SEDAR filings for
further details. Various assumptions or factors are typically
applied in drawing conclusions or making the forecasts or
projections set out in forward-looking information. Those
assumptions and factors are based on information currently
available to the parties. The material factors and assumptions
include the Company being able to obtain the necessary corporate,
regulatory and other third-party approvals, and licensing and other
risks associated with the Cannabis Act. The forward-looking
information contained in this release is made as of the date hereof
and the parties are not obligated to update or revise any
forward-looking information, whether as a result of new
information, future events or otherwise, except as required by
applicable securities laws. Because of the risks, uncertainties and
assumptions contained herein, investors should not place undue
reliance on forward-looking information. The foregoing statements
expressly qualify any forward-looking information contained
herein.
SOURCE 48North Cannabis Co.